Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Equity Ratio (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Equity Ratio for 12 consecutive years, with 0.72 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 124.84% to 0.72 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.72 through Dec 2025, up 124.84% year-over-year, with the annual reading at 0.72 for FY2025, 124.84% up from the prior year.
  • Equity Ratio hit 0.72 in Q4 2025 for vTv Therapeutics, up from 0.71 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.72 in Q4 2025 to a low of 3.36 in Q1 2021.
  • Historically, Equity Ratio has averaged 0.52 across 5 years, with a median of 0.35 in 2021.
  • Biggest five-year swings in Equity Ratio: crashed 593.22% in 2023 and later skyrocketed 172.04% in 2024.
  • Year by year, Equity Ratio stood at 0.38 in 2021, then grew by 15.49% to 0.32 in 2022, then plummeted by 593.22% to 2.24 in 2023, then surged by 114.23% to 0.32 in 2024, then surged by 124.84% to 0.72 in 2025.
  • Business Quant data shows Equity Ratio for VTVT at 0.72 in Q4 2025, 0.71 in Q3 2025, and 0.09 in Q2 2025.